Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome
Titel:
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome
Auteur:
Derosa, G. D'Angelo, A. Ragonesi, P. D. Ciccarelli, L. Piccinni, M. N. Pricolo, F. Salvadeo, S. A. T. Montagna, L. Gravina, A. Ferrari, I. Paniga, S. Cicero, A. F. G.